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Abstract
We surveyed pediatric antimicrobial stewardship program (ASP) site leaders within the Sharing Antimicrobial Reports for Pediatric
Stewardship collaborative regarding discharge stewardship practices. Among 67 sites, 13 (19%) reported ASP review of discharge antimicrobial prescriptions. These findings highlight discharge stewardship as a potential opportunity for improvement during the hospital-to-home
transition.
(Received 17 March 2021; accepted 15 June 2021)

Pediatric antimicrobial stewardship programs (ASPs) have been
shown to improve patient outcomes and reduce antibiotic overuse.1 Despite these efforts, inappropriate antibiotic prescribing
continues to occur in children’s hospitals. A study of 32 children’s
hospitals demonstrated that one-quarter of pediatric inpatients
treated with antibiotics received suboptimal therapy, with half of
suboptimal use not captured by ASP review.2 In addition, there
are concerns that antibiotic prescribing at hospital discharge is also
often inappropriate.3 Approximately 30% of pediatric discharges
include an antibiotic prescription,3 and in one single-center pediatric study, 27% of antibiotic prescriptions at discharge were suboptimal.4 Discharge stewardship interventions by adult ASPs have
resulted in improved prescribing,5,6 however, pediatric ASP oversight for children prescribed antibiotics at discharge has not been
widely described. The objective of this study was to describe the
current state of antimicrobial stewardship activities at discharge
among hospitals with a pediatric ASP.
Methods
We conducted a cross-sectional survey of institutions in the
Sharing Antimicrobial Reports for Pediatric Stewardship (SHARPS)
collaborative from April to July 2019. The SHARPS collaborative
includes >70 children’s hospitals and general hospitals with
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pediatric beds and aims to establish best practices for antimicrobial
use among hospitalized children.7
One SHARPS collaborative physician or pharmacist from each
US-based hospital was e-mailed the survey invitation and up to
3 reminders, which was administered through a secure Research
Electronic Data Capture (REDCap) tool hosted at Stanford
University. Survey completion indicated consent to participate.
The Institutional Review Board of Stanford University approved
this study.
Survey items asked about hospital practice setting, locations
of ASP oversight, ASP review of discharge prescriptions, and
discharge stewardship strategies used. Respondents rated the perceived frequency of problems with discharge antibiotic prescriptions at their institution using a Likert scale: rarely (<10% of the
time), sometimes (11%–49% of the time), or often (≥50% of the
time). Respondents then ranked the 3 highest priorities that
needed to be addressed regarding discharge antibiotic prescribing. The survey instrument is available in Supplementary File 1
(online).
Survey items were developed by the investigator group, which
consisted of pediatric infectious diseases clinicians. Investigators
reviewed each item for importance, applicability, and clarity to
establish content validity, and items were revised accordingly.
The survey was reviewed by noninvestigator experts in pediatric
infectious diseases for readability, interpretation, and understanding, pilot tested to assess functionality, and then distributed
through REDCap.
Responses were reported using descriptive summary statistics.
Data were analyzed using Stata version 15 software (StataCorp,
College Station, TX).
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Table 1. Characteristics and Discharge Stewardship Activities of Participating
SHARPS Hospitals
No., (%)
(n = 67)a

Characteristic
Practice setting
Free standing academic/university children’s hospital

38 (57)

Non-free standing, academic/university-affiliated
hospital with pediatric beds

21 (31)

Free standing community children’s hospital

6 (9)

Community hospital with pediatric beds

2 (3)

No. of pediatric beds
≤100

6 (9)

101–200

21 (31)

201–300

19 (28)

>300

21 (31)

Table 2. Types of Prescriptions Reviewed by ASP at Discharge
Types of Antimicrobial Prescriptions Reviewed

No., (%)
(n = 13)

IV restricted antimicrobials

3 (23)

All IV antimicrobials

7 (54)

Oral restricted antimicrobials

4 (31)

All oral antimicrobials

5 (38)

Other

a

2 (15)

Note. ASP, antimicrobial stewardship program; IV, intravenous.
a
1 site reviewed all discharge prescriptions for one service (hospital medicine), and 1 site
reviewed durations for 6 common antibiotics.

ASP review of discharge prescriptions

13 (28)

Inpatient (non-ASP) pharmacist review of discharge
prescriptions

22 (47)

Of 47 sites with discharge stewardship strategies, 22 (47%)
reported that non-ASP pharmacists reviewed discharge antimicrobials. Stewardship by non-ASP pharmacists comprised a wide
spectrum, from review of all discharge antimicrobial prescriptions
by an inpatient or transitions of care pharmacist to review at the
discretion of the pharmacist following up on their own patients.
Other strategies by non-ASP pharmacists included pharmacist
review through discharge rounds conducted daily or twice weekly
and inpatient pharmacist review through a bedside medication
delivery program. The most common discharge stewardship strategy was clinical guidelines or pathways that recommended appropriate discharge antibiotics for specific infections, reported by 35
sites (74%). Ten sites (21%) reported having electronic decision
support to promote stewardship, such as discharge antibiotic order
sets, based on clinical guidelines.
The most commonly perceived problems with discharge antibiotic prescribing were incorrect duration of therapy, inappropriate drug selection, and incorrect dose, which corresponded directly
with 3 highest priorities identified for discharge stewardship interventions (Supplementary Fig. 1 online).

Clinical practice guidelines or pathways

35 (74)

Discussion

10 (21)

In this national survey of pediatric discharge antimicrobial stewardship practices, most pediatric ASPs reported that they do not
perform review of antimicrobial prescriptions at the time of
discharge. With an estimated 30% of hospitalized children discharged with an antibiotic prescription,3 these findings highlight discharge stewardship as an opportunity for improvement
during the transition from hospital to home. Although ASP leaders
perceived that discharge antimicrobial errors were common, multicenter pediatric data on appropriateness of discharge antibiotic
prescriptions are needed to fully understand the scope of the
problem.
The optimal approach to discharge antimicrobial stewardship
remains unknown, including who should provide oversight, what
strategies for pharmacist review should be utilized, and which
patient populations and medications to target. ASP strategies
for antimicrobial review, such as prospective audit with real-time
feedback and approval/denials of restricted antimicrobials,
have been successful in improving appropriate antimicrobial
use for hospitalized children,8 but these have not been studied
for pediatric discharge prescriptions. One adult discharge stewardship intervention utilizing prospective audit with real-time
feedback was associated with decreased use of antibiotics
with broad gram-negative coverage and shorter treatment durations after discharge.6 Although pharmacist-led medication
reconciliation and review has been associated with decreases in

Region
Northeast

13 (19)

Midwest

19 (28)

South

23 (34)

West

12 (18)

Settings at the institution with ASP involvement
Inpatient

67 (100)

Emergency department

37 (55)

Outpatient clinics

23 (34)

Sites with discharge stewardship strategies

47 (70)

Type of discharge stewardship strategy usedb (n = 47)

Electronic decision support

b

Note. SHARPS, Sharing Antimicrobial Reports for Pediatric Stewardship; ASP, antimicrobial
stewardship program.
a
Percentages may not add up to 100 due to rounding.
b
Percentages add up to >100 because sites could report using >1 strategy.
c
Examples of electronic decision support include discharge order sets and Smart tools.

Results
The survey was completed by 67 of 74 (91%) institutions in the
SHARPS collaborative (Table 1); 42 (63%) were ASP medical
directors, 22 (33%) were pharmacists, and 3 (4%) were other infectious diseases physicians.
Overall, 47 (70%) sites reported using 1 or more of the following
discharge stewardship strategies: ASP review of discharge prescriptions, non-ASP pharmacist review of discharge prescriptions, clinical pathways and guidelines, and/or electronic decision support
(Table 1). Of the 47 sites with discharge stewardship strategies,
13 (28%) reported ASP review of discharge prescriptions. Specific
strategies used for discharge prescription review included prospective audit with real-time feedback and approval or denial of
restricted antimicrobials. At 3 sites, all discharge antimicrobials
were reviewed, and at the remaining 10 sites, specific subgroups
(eg, oral, IV, or restricted antimicrobials) were reviewed (Table 2).
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medical errors, readmission, and ED visits,9 programs may be
limited in the resources they have to implement such efforts.
In addition, guidelines, pathways, and decision support tools
for optimal prescribing of antimicrobials continue to evolve.
Efforts to standardize care through institutional guidelines have
been shown to improve appropriate antibiotic prescribing for
infections such as community-acquired pneumonia.10 Such
guidelines are considered an important aspect of inpatient stewardship strategies because they provide evidence-based treatment recommendations based on local data, and they may
require fewer resources than pharmacist review of discharge
prescriptions.1
This study has several limitations. First, we only surveyed
leaders from SHARPS collaborative institutions, which are
mostly university-affiliated and already have ASPs. Second, we
only surveyed one leader per site. Perceived problems and priorities may have differed by respondent, even within the same
program. Third, as most institutions do not regularly collect data
on the appropriateness of discharge antibiotics, we were unable
to compare perceived problems with actual institutional
data. Fourth, we did not collect detailed data on categories of
antimicrobials reviewed by non-ASP pharmacists or whether
they also performed medication reconciliation. Lastly, we were
unable to evaluate the effectiveness of reported stewardship
interventions.
In conclusion, despite the growing evidence for inappropriate antibiotic use as patients transition from hospital to home,
most pediatric ASPs do not review discharge antimicrobial
prescriptions. Opportunities may exist for improvements in
prescribing at discharge, including drug selection, dose, and
duration. Future research should characterize the extent of
inappropriate discharge prescribing across multiple institutions to better inform the development of discharge stewardship interventions.
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